Formed MedShadow Foundation, the parent company of two nonprofits, MedShadow (2012) and DES Action USA (acquired in 2015). MedShadow’s mission is to inform the public on the side effects, risks and benefits of prescription and OTC medications. DES Action (founded in 1978) educates, empowers and advocates for the millions of women who were given DES in pregnancy in the 1950s, 60s and early 70s. The world’s first synthetic estrogen, DES was thought to prevent miscarriage and early labor. It did neither and instead left the mother, her child and subsequent generations (estimated at 5 million people in 2015) at risk for rare cancers and other serious medical conditions. MedShadow Foundation is a 501c3 nonprofit organization and accepts no advertising or monetary support from pharmaceutical companies or healthcare provider organizations.

The committee advises the Federal Drug Administration commissioner on risk management, risk communication, and quantitative evaluation of adverse event reports for drugs for which the FDA has regulatory responsibility. The Committee also advises the Commissioner of Food and Drugs regarding the scientific and medical evaluation of all information gathered by the Department of Health and Human Services and the Department of Justice with regard to safety, efficacy, and abuse potential of drugs or other substances, and recommends actions to be taken by the Department of Health and Human Services with regard to the marketing, investigation, and control of such drugs or other substances.Committee MembershipThe Committee shall consist of a core of 11 voting members including the Chair. Members and the Chair are selected by the Commissioner or designee from among authorities knowledgeable in risk communication, risk management, drug safety, medical, behavioral, and biological sciences as they apply to risk management, and drug abuse. The core of voting members may include one technically qualified member, selected by the Commissioner or designee, who is identified with consumer interests and is recommended by either a consortium of consumer-oriented organizations or other interested persons. In addition to the voting members, the Committee may include one non-voting member who is identified with industry interests.

Community Board 7/Manhattan is part of local New York City government and plays an important advisory role in dealing with multiple community concerns of Manhattan’s Upper West Side. Committee participation includes: Business-Consumer Issues (2012-present), Steering (2011-present), Housing (2010-present), Park & Environment (2010-2012)

Advisor to Pace University’s Master of Science degree in Publishing Program, providing professional insight and guidance ensuring curriculum was in alignment with rapidly changing publishing industry needs and digital technology.

The Board of Directors serve as champions in support of the West Side YMCA’s mission, goals, and directives through leadership, advisement, financial support, and advocacy.

Variety Boys & Girls Club of Queens is the largest after-school program in Western Queens. The Club functions as a neighborhood anchor, offering children a safe haven to learn, play, and grow into tomorrow's leaders.

Clients included: Every Woman magazine, Environmental First Search, Hasco/GrowingFamily.com, Beehive Bee Products

•Created and launched a specialty publishing company targeting expectant and new mothers as well as childbirth educators. Publications were distributed through unique channels including diaper service, hospital (newborn care pack) and childbirth instructors• Raised investment capital, sold advertising to blue chip brands (American Home Products, Pfizer, Kimberly Clark), negotiated printing, distribution and Internet contracts, hired and managed staff•Sold Baby Publishing, LLC to Gruner+ Jahr Bertelsmann, the global publishing company

Maintained and increased advertising sales for magazine publisher targeting expectant and new mothers